E U G E N E V M O N A C O
Principal | MediTechnix Incorporated | gene.monaco@meditechnix.com | 412.657.7739
Full Curriculum Vitae and Bona Fides available upon request
Gene works to improve healthcare
industry integrated performance through the MediTechnix consulting and
technology application group. He has ultimate responsibility for design,
execution, and quality of work of the Firm. Firm professionals include expert
engineers, physicians, macro data strategists, financiers, quality
professionals, and information technology and biometric scientists.
Gene is sought-out by healthcare professionals as a creative
challenge solver and has evolved into a thought leader. Always vigilant for a
professional challenge, he has been drawn to the healthcare industry because of
its sheer multidisciplinary complexity, and the quantum leap it is undergoing
in his domain expertise of management engineering. Analogous to the management
engineering approach taken by the Mayo Clinic, Gene has already successfully
migrated numerous lessons learned and models from other industries into deployment
for his healthcare clients.
Commissioned by several physician and
administrative leaders, Gene’s multidisciplinary working groups have isolated
innumerable high ROI opportunities to increase “Triple Pillar” integrated
performance in healthcare (i.e., patient outcomes, patient satisfaction,
economic efficiency), further evidencing the axiom that “good medicine is good
business”. Resultantly, he has concentrated on efficient opportunity isolation
assessment techniques, and creating, adapting, and implementing improved and
new data-driven evidence-based medicine management models and technologies to
meet these needs in healthcare.
His healthcare consulting and technology application
experience primarily extends to Transplant, Emergency Department, Interventional Cardiology, Pharmacy, and others, with numerous
intersections with clinical infrastructures, nursing and tech operations,
patient processing methods, and external factors such as quantification and stochastic
forecasting of patient supply and capacities demanded.
Gene has previously designed industry-changing disruptive
technology processes for Ford, Nortel, and Xerox with several billion dollars
of bottom-line impact using a Technoeconomic Modeling Technique he created at
Carnegie Mellon University. This Technique enables determination of economic worth, risk
management, fault isolation and abatement, and efficiency and quality
improvements typically associated with the well-regarded Toyota Production
System. Importantly, this method also provides a structured basis for change
management and performance measurement. This work was also foundational to
CMU’s Green Design Initiative; better quality and economics, with less
resources and waste.
Gene began his career in capital markets where he had senior
investment banking responsibility for 23 public finance offerings, with
significant work in financing and development of greenfield and brownfield
commercial real estate. He subsequently began a consulting and private finance
career serving Fortune 100, government, private equity, philanthropic, and
non-profit clients in 50+ major successful projects and private placements.
Gene holds MS Certificates in both Project Management (PMI),
and Business Analysis (IIBA), from the University of Pittsburgh Katz School EMBA
Program, as well as the Lean Six Sigma Black Belt (CSSBB) in process
improvement and new process design. He was granted a BS Cum Laude in Business
Administration from the University of Pittsburgh, and a BS in Civil Engineering
from Carnegie Mellon, receiving the Outstanding Senior Thesis Award. The
recipient of the IBM Fellowship to underwrite his research, Gene completed an
MS in Civil Engineering, also at Carnegie Mellon, ranking first in his class.
Gene joined the Committee for Oversight in Organ
Transplantation (COOT) in December 2012.
